SPTX

Seaport Therapeutics, Inc.

Healthcare · Biotechnology

17.90$ -0.1% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Cash Flow SPTX
Line item	Q1 25	Q1 26	Q2 26
Operating Cash Flow	–	-0.38	-0.49
Depreciation & Amortization	–	0.01	0.01
Stock-Based Compensation	–	0.05	–
Change in Working Capital	–	0.05	-0.01
Capital Expenditures	–	0.00	0.00
Investing Cash Flow	–	0.53	-3.80
Financing Cash Flow	–	-0.01	4.50
Change in Cash	–	0.13	0.21
Free Cash Flow	–	-0.38	-0.49

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.